News
Netflix Co-Founder Says You Don't Need MBA Or Investors To Start A Business: 'Search For Pain… And Fall In Love With Trying To Solve Problems'
1 Jun 24
News, Tech
Donald Trump Campaign Raises $52.8M In 24 Hours Post Guilty Verdict: More Than A Third Of The Donors Said To Be New
1 Jun 24
News, Politics, Media
Elon Musk Reveals Tesla's FSD Will Have Three Modes For Drivers To Choose From: 'Chill, Standard And Hurry'
1 Jun 24
News, Tech
Joe Biden Vetoes Bipartisan Resolution To Overturn SEC's Crypto Custody Guidance: '...Will Not Support Measures That Jeopardize Well-Being Of Consumers And Investors'
1 Jun 24
Cryptocurrency, News, Politics, Markets, Tech, Media
Nissan Pays Ex-COO Ashwani Gupta $3.7M As Compensation For Leaving Amid Sexual Harassment Allegations
1 Jun 24
News, Tech
Elon Musk Faces $7.5B Insider Trading Allegation From Tesla Shareholder
31 May 24
News, Legal, Tech, General
Israel's Benjamin Netanyahu Invited To Address Congress By Bipartisan Leaders Amid ICC War Crimes Allegations
31 May 24
News, Politics, Global, Media
10% Of Republicans Less Likely To Vote For Trump In Presidential Elections After Felony Conviction: Poll
31 May 24
News, Politics
Tesla's Humanoid Bot Optimus Guides Shareholders On Voting Process Ahead Of Key June Meeting
31 May 24
News, Tech
Summit Therapeutics Ivonescimab In Combination with Chemotherapy Approved In China By NMPA For 2L+ EGFRm NSCLC Based On HARMONi-A Clinical Trial; Clinically Meaningful Efficacy Observed In Overall Survival Towards Ivonescimab Plus Chemotherapy; Shares Currently Halted
31 May 24
Biotech, News, Global, Trading Ideas, General
Ivanka Trump Breaks Silence After Ex-President's Guilty Verdict In Hush Money Case: 'I Love You Dad'
31 May 24
News, Politics, Media
EXCLUSIVE: Trump's Guilty Verdict Sparks Brief Overreaction In 2024 Election Betting Odds, But He 'Remains The Favorite To Be The Next President'
31 May 24
Sports Betting, Politics, Top Stories, Exclusives
Netflix Posts On X "Unfortunately Jake Paul And Mike Tyson Will Not Face-Off On July 20 As Planned. Tyson's Recent Ulcer Flare Up Has Limited His Ability To Train Fully For The Next Few Weeks. The Fight Will Be Rescheduled For A Date Later This Year"
31 May 24
News, Events
$100 Invested In CDW 5 Years Ago Would Be Worth This Much Today
31 May 24
News, Trading Ideas
Here's How Much You Would Have Made Owning Linde Stock In The Last 20 Years
31 May 24
News, Trading Ideas
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
31 May 24
News, Trading Ideas
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
31 May 24
News, Trading Ideas
Delaware Expands Medical Cannabis Access, Grants Physicians Discretion For Recommendations, Opens Dispensaries To Out-Of-State Patients
31 May 24
Cannabis, Government, Regulations
RCI Hospitality Shares Swing Wildly Following Raid Allegations From Short Report: What Investors Should Know
31 May 24
Movers, Trading Ideas
Barrington Research Maintains Outperform on ICF International, Maintains $173 Price Target
31 May 24
News, Price Target, Analyst Ratings
Press releases
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
1 Jun 24
Press Releases
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cambium Networks
1 Jun 24
Press Releases
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
1 Jun 24
Press Releases
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
1 Jun 24
Press Releases
Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (NYSE: WOW) and Encourages Investors to Contact the Firm
1 Jun 24
News, Legal, Press Releases
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
1 Jun 24
Press Releases
Pfizer's ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
1 Jun 24
Press Releases
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
1 Jun 24
News, Press Releases
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
1 Jun 24
Press Releases
OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
1 Jun 24
Press Releases
CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
1 Jun 24
Press Releases
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
1 Jun 24
Press Releases
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
1 Jun 24
Press Releases
Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
1 Jun 24
Press Releases
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
1 Jun 24
Press Releases
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
1 Jun 24
Press Releases
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
1 Jun 24
Press Releases
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
1 Jun 24
Press Releases
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
1 Jun 24
Press Releases
Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible patients
1 Jun 24
Press Releases